Metraipolis › archive › dc_90b800ca07c2
YRDC is a Prognostic-Related Biomarker Correlated With Immune Infiltration and Drug Sensitivity in Pan-Cancer — Europe PMC PMID:40898423
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40898423
- DOI
- 10.1002/cnr2.70325
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:59:17.867Z
- SHA-256 of the archived text
ff831a9629ec300d3c611814c763fcff1d00180165bbb7b7b5095dac1b346be6- Stable URL of this page
https://metraipolis.com/documento/dc_90b800ca07c2
How to cite
YRDC is a Prognostic-Related Biomarker Correlated With Immune Infiltration and Drug Sensitivity in Pan-Cancer — Europe PMC PMID:40898423 — Europe PMC (en), https://europepmc.org/article/MED/40898423 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_90b800ca07c2 (Metraipolis archive dc_90b800ca07c2, sha256 ff831a9629ec300d3c611814c763fcff1d00180165bbb7b7b5095dac1b346be6)
BibTeX
@misc{dc90b800ca07c2,
title = {YRDC is a Prognostic-Related Biomarker Correlated With Immune Infiltration and Drug Sensitivity in Pan-Cancer — Europe PMC PMID:40898423},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40898423},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_90b800ca07c2; sha256 ff831a9629ec300d3c611814c763fcff1d00180165bbb7b7b5095dac1b346be6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40898423. Agents can read the archived copy with the MCP tool read_document.